MARÍA DOLORES
CABALLERO BARRIGÓN
Ikertzailea 1998-2022 tartean
University of Pittsburgh Cancer Institute
Pittsburgh, Estados UnidosUniversity of Pittsburgh Cancer Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2018
-
Ibrutinib as treatment for patients with relapsed/refractory follicular lymphoma: Results from the open-label, multicenter, phase II DAWN study
Journal of Clinical Oncology, Vol. 36, Núm. 23, pp. 2405-2412